001     602646
005     20250724152303.0
024 7 _ |a 10.1107/S2053273322093986
|2 doi
024 7 _ |a 0108-7673
|2 ISSN
024 7 _ |a 0567-7394
|2 ISSN
024 7 _ |a 1600-5724
|2 ISSN
024 7 _ |a 1600-8596
|2 ISSN
024 7 _ |a 2053-2733
|2 ISSN
024 7 _ |a 10.3204/PUBDB-2024-00707
|2 datacite_doi
024 7 _ |a WOS:001048207700273
|2 WOS
024 7 _ |a openalex:W4327802362
|2 openalex
037 _ _ |a PUBDB-2024-00707
041 _ _ |a English
082 _ _ |a 530
100 1 _ |a Chatziefthymiou, S.
|0 P:(DE-H253)PIP1094717
|b 0
|u desy
245 _ _ |a Inhibitor screening and structural characterization of virulence factors from SARS-CoV-2
260 _ _ |a Oxford [u.a.]
|c 2022
|b Blackwell
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1707485184_137524
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Coronavirus induced zoonotic diseases can cause pandemics with unforeseeable consequences to human health and global economy. Our project aims to screen and develop effective therapeutics against SARS-CoV-2, targeting its replication-transcription complex (RTC). Following an interdisciplinary research approach, compound libraries of approved drugs are used for the discovery of potent inhibitors for proteins of the RTC and the binding mode of these enzymeinhibitor complexes is studied by X-ray crystallography. Our workflow includes the production of proteins involved in the coronavirus RTC, the high-throughput inhibitor screening with fluorescence-based assays using drug repurposing libraries and the structure/function analysis of the identified enzyme-inhibitor complexes. The advantages of this approach is that it is cost efficient, high-throughput, allows the direct identification of potent inhibitors and ensures optimal beamtime usage. Furthermore, such a platform can be successfully used in future viral outbreaks. In this presentation we will give an overview of this project and the results achieved to date. We will focus on one of the target proteins, namely the uridine-specific endoribonuclease nsp15, and apart from the results from its inhibitor screening we will also present findings that allowed us to shed light on important activity determinants of this enzyme.
536 _ _ |a 633 - Life Sciences – Building Blocks of Life: Structure and Function (POF4-633)
|0 G:(DE-HGF)POF4-633
|c POF4-633
|f POF IV
|x 0
536 _ _ |a 6G3 - PETRA III (DESY) (POF4-6G3)
|0 G:(DE-HGF)POF4-6G3
|c POF4-6G3
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, Journals: bib-pubdb1.desy.de
693 _ _ |a PETRA III
|f PETRA Beamline P11
|1 EXP:(DE-H253)PETRAIII-20150101
|0 EXP:(DE-H253)P-P11-20150101
|6 EXP:(DE-H253)P-P11-20150101
|x 0
700 1 _ |a Kuzikov, M.
|b 1
700 1 _ |a Afandi, S.
|0 P:(DE-H253)PIP1096213
|b 2
700 1 _ |a Crosas, E.
|0 P:(DE-H253)PIP1023241
|b 3
|u desy
700 1 _ |a Pompidor, G.
|0 P:(DE-H253)PIP1018389
|b 4
|u desy
700 1 _ |a Taberman, H.
|0 P:(DE-H253)PIP1086480
|b 5
|u desy
700 1 _ |a Windschügel, B.
|b 6
700 1 _ |a Labahn, Joerg
|0 P:(DE-H253)PIP1017946
|b 7
700 1 _ |a Kolbe, M.
|0 P:(DE-H253)PIP1021134
|b 8
700 1 _ |a Hakanpää, J.
|0 P:(DE-H253)PIP1013442
|b 9
|u desy
773 _ _ |a 10.1107/S2053273322093986
|g Vol. 78, no. a2, p. e333 - e333
|0 PERI:(DE-600)2020844-3
|n a2
|p e333
|t Acta crystallographica / Section A
|v 78
|y 2022
|x 0108-7673
856 4 _ |y OpenAccess
|u https://bib-pubdb1.desy.de/record/602646/files/a61451.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://bib-pubdb1.desy.de/record/602646/files/a61451.pdf?subformat=pdfa
909 C O |o oai:bib-pubdb1.desy.de:602646
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Elektronen-Synchrotron
|0 I:(DE-588b)2008985-5
|k DESY
|b 0
|6 P:(DE-H253)PIP1094717
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 2
|6 P:(DE-H253)PIP1096213
910 1 _ |a Deutsches Elektronen-Synchrotron
|0 I:(DE-588b)2008985-5
|k DESY
|b 3
|6 P:(DE-H253)PIP1023241
910 1 _ |a European Molecular Biology Laboratory
|0 I:(DE-588b)235011-7
|k EMBL
|b 3
|6 P:(DE-H253)PIP1023241
910 1 _ |a Deutsches Elektronen-Synchrotron
|0 I:(DE-588b)2008985-5
|k DESY
|b 4
|6 P:(DE-H253)PIP1018389
910 1 _ |a European Molecular Biology Laboratory
|0 I:(DE-588b)235011-7
|k EMBL
|b 4
|6 P:(DE-H253)PIP1018389
910 1 _ |a Deutsches Elektronen-Synchrotron
|0 I:(DE-588b)2008985-5
|k DESY
|b 5
|6 P:(DE-H253)PIP1086480
910 1 _ |a European Molecular Biology Laboratory
|0 I:(DE-588b)235011-7
|k EMBL
|b 5
|6 P:(DE-H253)PIP1086480
910 1 _ |a Centre for Structural Systems Biology
|0 I:(DE-H253)_CSSB-20140311
|k CSSB
|b 7
|6 P:(DE-H253)PIP1017946
910 1 _ |a Centre for Structural Systems Biology
|0 I:(DE-H253)_CSSB-20140311
|k CSSB
|b 8
|6 P:(DE-H253)PIP1021134
910 1 _ |a European Molecular Biology Laboratory
|0 I:(DE-588b)235011-7
|k EMBL
|b 8
|6 P:(DE-H253)PIP1021134
910 1 _ |a Deutsches Elektronen-Synchrotron
|0 I:(DE-588b)2008985-5
|k DESY
|b 9
|6 P:(DE-H253)PIP1013442
913 1 _ |a DE-HGF
|b Forschungsbereich Materie
|l Von Materie zu Materialien und Leben
|1 G:(DE-HGF)POF4-630
|0 G:(DE-HGF)POF4-633
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-600
|4 G:(DE-HGF)POF
|v Life Sciences – Building Blocks of Life: Structure and Function
|x 0
913 1 _ |a DE-HGF
|b Forschungsbereich Materie
|l Großgeräte: Materie
|1 G:(DE-HGF)POF4-6G0
|0 G:(DE-HGF)POF4-6G3
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-600
|4 G:(DE-HGF)POF
|v PETRA III (DESY)
|x 1
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-22
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ACTA CRYSTALLOGR A : 2022
|d 2023-10-22
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2023-10-22
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-22
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-22
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-22
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-22
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-22
920 1 _ |0 I:(DE-H253)FS-PETRA-D-20210408
|k FS-PETRA-D
|l PETRA-D
|x 0
920 1 _ |0 I:(DE-H253)ITT-20160816
|k ITT
|l Innovation & Technologietransfer
|x 1
920 1 _ |0 I:(DE-H253)HAS-User-20120731
|k DOOR ; HAS-User
|l DOOR-User
|x 2
920 1 _ |0 I:(DE-H253)CSSB-HZI-MK-20210520
|k CSSB-HZI-MK
|l CSSB-HZI-MK
|x 3
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-H253)FS-PETRA-D-20210408
980 _ _ |a I:(DE-H253)ITT-20160816
980 _ _ |a I:(DE-H253)HAS-User-20120731
980 _ _ |a I:(DE-H253)CSSB-HZI-MK-20210520
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21